dexetimide , CAS No.21888-98-2, Antagonist of M 2 receptor

Item Number
D609848
Grouped product items
SKUSizeAvailabilityPrice Qty
D609848-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,400.90
D609848-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90
View related series
M2 receptor Antagonist

Basic Description

SynonymsDEXETIMIDE | 21888-98-2 | Tremblex | (+)-Benzetimide | Dexbenzetimide | Benzetimide, (s)- | R 16470 | R 16,470 [as hydrochloride] | (3S)-3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione | 43477QYX3D | (+)-2-(1-Benzyl-4-piperidyl)-2-phenylglutarimide | Dexbenzelimid | Sere
Specifications & PurityMoligand™
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of M 2 receptor

Associated Targets(Human)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Associated Targets(non-human)

Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name (3S)-3-phenyl-3-[1-(phenylmethyl)piperidin-4-yl]piperidine-2,6-dione
INCHI InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)/t23-/m1/s1
InChi Key LQQIVYSCPWCSSD-HSZRJFAPSA-N
Canonical SMILES O=C1CC[C@](C(=O)N1)(C1CCN(CC1)Cc1ccccc1)c1ccccc1
Isomeric SMILES C1CN(CCC1[C@@]2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4
PubChem CID 30843

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Huygens H, Vereecken JL, Tanghe A.  (1973)  Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action..  Psychiatr Neurol Neurochir,  76  (4): (251-9).  [PMID:4581374]
2. Dom R, Van Lommel R, Baro F.  (1971)  A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent..  Acta Psychiatr Scand,  47  (4): (399-410).  [PMID:4947805]

Solution Calculators